Literature DB >> 12755456

The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans.

Richard W Foltin1, Amie S Ward, Eric D Collins, Margaret Haney, Carl L Hart, Marian W Fischman.   

Abstract

The effects of maintenance on venlafaxine, which blocks both norepinephrine and serotonin reuptake, on the response to smoked cocaine (0, 12, 25, or 50 mg) in 7 opioid-free and 7 methadone-maintained cocaine abusers was examined during a 42-day study. Participants received venlafaxine (225 mg daily) and placebo as part of a double-blind crossover design. Cocaine significantly increased heart rate, blood pressure, cocaine choice, cocaine ratings, and ratings of positive subjective effects (e.g., "I feel high") in both groups. Venlafaxine significantly decreased the subjective effects of cocaine by 10-20% without affecting cocaine choice or cardiovascular response in both groups. Although the reduction in cocaine's effects was small, further studies using a longer venlafaxine maintenance period or a larger venlafaxine dose are warranted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12755456     DOI: 10.1037/1064-1297.11.2.123

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  9 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

Review 2.  A qualitative and quantitative review of cocaine-induced craving: the phenomenon of priming.

Authors:  James J Mahoney; Ari D Kalechstein; Richard De La Garza; Thomas F Newton
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-01-31       Impact factor: 5.067

Review 3.  Controversies in translational research: drug self-administration.

Authors:  Margaret Haney; Roger Spealman
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

4.  Cocaine cue versus cocaine dosing in humans: evidence for distinct neurophysiological response profiles.

Authors:  Malcolm S Reid; Frank Flammino; Bryant Howard; Diana Nilsen; Leslie S Prichep
Journal:  Pharmacol Biochem Behav       Date:  2008-07-11       Impact factor: 3.533

Review 5.  Recent advances in the pharmacotherapy of cocaine dependence.

Authors:  Charles A Dackis
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

6.  Relationship between intranasal cocaine self-administration and subject-rated effects: predictors of cocaine taking on progressive-ratio schedules.

Authors:  Justin C Strickland; Joshua A Lile; Craig R Rush; William W Stoops
Journal:  Hum Psychopharmacol       Date:  2014-05-19       Impact factor: 1.672

Review 7.  Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.

Authors:  Paul W Czoty; William W Stoops; Craig R Rush
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

8.  Reduction of Methylphenidate Induced Anxiety, Depression and Cognition Impairment by Various doses of Venlafaxine in Rat.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Andia Ebrahimzadeh; Setare Farokhi Larijani; Zohreh Khajehamedi
Journal:  Int J Prev Med       Date:  2015-06-04

9.  Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaine.

Authors:  Diana Martinez; Mark Slifstein; Rajesh Narendran; Richard W Foltin; Allegra Broft; Dah-Ren Hwang; Audrey Perez; Anissa Abi-Dargham; Marian W Fischman; Herbert D Kleber; Marc Laruelle
Journal:  Neuropsychopharmacology       Date:  2009-01-28       Impact factor: 7.853

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.